1. Home
  2. ACOG vs ZENV Comparison

ACOG vs ZENV Comparison

Compare ACOG & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • ZENV
  • Stock Information
  • Founded
  • ACOG 2000
  • ZENV 2005
  • Country
  • ACOG Canada
  • ZENV Brazil
  • Employees
  • ACOG N/A
  • ZENV N/A
  • Industry
  • ACOG
  • ZENV Computer Software: Prepackaged Software
  • Sector
  • ACOG
  • ZENV Technology
  • Exchange
  • ACOG Nasdaq
  • ZENV Nasdaq
  • Market Cap
  • ACOG 80.3M
  • ZENV 80.2M
  • IPO Year
  • ACOG N/A
  • ZENV 2021
  • Fundamental
  • Price
  • ACOG $9.74
  • ZENV $1.23
  • Analyst Decision
  • ACOG Strong Buy
  • ZENV
  • Analyst Count
  • ACOG 1
  • ZENV 0
  • Target Price
  • ACOG $20.00
  • ZENV N/A
  • AVG Volume (30 Days)
  • ACOG 196.9K
  • ZENV 94.4K
  • Earning Date
  • ACOG 05-15-2025
  • ZENV 05-16-2025
  • Dividend Yield
  • ACOG N/A
  • ZENV N/A
  • EPS Growth
  • ACOG N/A
  • ZENV N/A
  • EPS
  • ACOG N/A
  • ZENV N/A
  • Revenue
  • ACOG $2,928,654.00
  • ZENV $155,164,999.00
  • Revenue This Year
  • ACOG N/A
  • ZENV $11.50
  • Revenue Next Year
  • ACOG N/A
  • ZENV $10.28
  • P/E Ratio
  • ACOG N/A
  • ZENV N/A
  • Revenue Growth
  • ACOG N/A
  • ZENV 18.83
  • 52 Week Low
  • ACOG $3.75
  • ZENV $1.02
  • 52 Week High
  • ACOG $11.40
  • ZENV $3.38
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • ZENV 35.47
  • Support Level
  • ACOG N/A
  • ZENV $1.20
  • Resistance Level
  • ACOG N/A
  • ZENV $1.30
  • Average True Range (ATR)
  • ACOG 0.00
  • ZENV 0.13
  • MACD
  • ACOG 0.00
  • ZENV -0.03
  • Stochastic Oscillator
  • ACOG 0.00
  • ZENV 10.96

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About ZENV Zenvia Inc.

Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.

Share on Social Networks: